- Approval Id
- b9eaa73d1b784267
- Drug Approval Sfda Name
- Bexsero
- Trade Name
- Bexsero
- Generic Name
- RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN THE NHBA,RECOMBINANT NEISSERIA MENINGITIDIS GROUP B NHBA FUSION PROTEIN THE NHBA I,RECOMBINANT N MENINGITIDIS SEROGROUP B NADA PROTEIN,RECOMBINANT N MENINGITIDIS SEROGROUP B NADA PROTEIN I,RECOMBINANT N MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN,RECOMBINANT N MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN I,OUTER MEMBRANE VESICLES FROM N MENINGITIDIS SEROGROUP B STRAIN NZ98254
- Register Number
- 1908200131
- Register Year
- 2020
- Drug Type
- Biological
- Route Of Administration
- Intramuscular use
- Package Type
- Pre-filled syringe
- Package Size
- 1
- Size
- 0.5
- Size Unit
- ml
- Legal Status
- Prescription
- Authorization Status
- Valid
- Marketing Status
- Marketed
- Product Control
- Uncontrolled
- Storage Conditions
- Store in a refrigerator (2°C – 8°C), do not freeze
- Shelf Life
- 48 Months
- Distribution Site
- Hospital
- Description Code
- 49000018025-350-200000016499
- Price
- 347.9
